首页> 外文会议>Conference on lasers in surgery: Advanced characterization, therapeutics, and systems >Improved diagnosis and therapy of superficial transitional cell carcinoma (TCC) of the urinary bladder by 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PPIX) fluorescence: a prospective study in 100 patients
【24h】

Improved diagnosis and therapy of superficial transitional cell carcinoma (TCC) of the urinary bladder by 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PPIX) fluorescence: a prospective study in 100 patients

机译:通过5-氨基乙酰丙烯酸(5-ALA)诱导的原子卟啉IX(PPIX)荧光(PPIX)荧光改善膀胱膀胱膀胱膀胱癌(TCC)的诊断和治疗:100名患者的前瞻性研究

获取原文

摘要

The prognosis of superficial bladder cancer is strongly related to a high recurrence rate and the presence of concomitant,, plane" tumor lesions uch as severe dysplasia or carcinoma in situ. They are frequently overlooked on white light cystoscopy. Furthermore, the traditional transurethral tumor resection of superficial bladder tumor is fredquently incomplete. This prospective study aimed to evaluate whether or not 5-ALA induced PPIX fluores-cence cystoscopy could increase the detection of superficial bladder tumors and/or ,, plane" carcinoma in situ invisible on white light cystoscopy. 100 patients with superficial TCC of the urinary bladder underwent cystoscopy under white light and under blue fluorescence light. 2 hours (1-4 hours) prior to cystoscopy 50 ml 3 per cent 5-ALA-solution were intravesically instilled into the empty bladder. All lesions visible on white light cystoscopy were compared with fluorescence findings and, vice versa, all fluorescence findings werde compared with white light cystoscopy findings. All lesions visible under white light, and all lesions only visible under 5-ALA induced fluorescence were resected/biopsied and histologically examined. A total 515 resections/biopsies was performed (5. 15 biopsies per patient). 297 tumors were detected, 257 of 297 (86.5 per cent) on white light, and 288 of 297 (96.7 per cent) on fluorescence cystoscopy. 9 of 297 tumors (3.0 per cent) were only detected by white light, but 31 of 297 tumors (10.4 per cent) were only detected by fluorescence cystoscopy, i.e. the mucosa was looking normal under white light but showed positive fluorescence; 7/77 (9.0 percent) pTaG1, 13/96 (13.5 per cent) pTaG2, 3/48 (6.3 per cent) pT1G2, 15/43 (34.9 per cent) pTaG3 or Cis and 2/23 (8.7 per cent) pT1G3 tumors. A total of 17 of 66 grade 3 superficial TCC would have been overlooked on white light cystoscopy, a finding of clinical importance. The sensitivity and specificity of white light cystos copy was 86.5 per cent and 45.4 per cent, respectively, wheras the sensitivity and specificity of fluorescence cystoscopy was 96.7 per cent and 26.6 per cent, respectively. No local or systemic side effects of intravesical instillation of 5-ALA solution was observed. In conclusion, ALA-induced fluorescence endoscopy proved to be a safe method to increase the tumor detection rate, especially the detection of carcinoma in situ and highly malignant pT1G3 tumors.
机译:浅表膀胱癌的预后与高复发率和伴随,平面“肿瘤病变uch原位的伴随,平面”肿瘤病变uch的存在强烈的。它们经常被忽略在白光膀胱镜上。此外,传统的经尿道肿瘤切除浅表膀胱肿瘤是令人满意的。这种前瞻性研究旨在评估5-ALA诱导的PPIX荧光血症膀胱诊断是否可以在白光膀胱镜检查上以原位看浅表膀胱肿瘤和/或平面“癌的检测。 100例患有膀胱膀胱的浅层TCC患者在白光下进行膀胱镜检查,在蓝色荧光下。在膀胱镜检查之前2小时(1-4小时)50mL 3%的5- ala-溶液在空膀胱中灌输。与白光膀胱镜检查相比,将白光膀胱镜检查的所有病变与荧光调查结果进行比较,反之亦然,所有荧光调查结果都是氟德。在白光下可见的所有病变,并且只在5 ALA诱导的荧光下可见的所有病变被切除/活检并组织学检查。进行总共515分切除术/活检(5.每位患者15个活组织检查)。在白光下检测297例肿瘤,257例297(86.5%),荧光膀胱镜检查288例297(96.7%)。仅通过白光检测297例肿瘤(3.0%),但仅通过荧光膀胱镜检查(10.4%),即297个肿瘤(10.4%),即白光在白色光下看起来正常,但显示出正荧光; 7/77(9.0%)PTAG1,13 / 96(13.5%)PTAG2,3 / 48(6.3%)PT1G2,15 / 43(34.9%)PTAG3或CIS和2/23(8.7%)PT1G3肿瘤。共有17级,共3年级的3级浅表TCC将被忽视在白光膀胱镜检查中,这是一种临床重要性。白光Cystos拷贝的敏感性和特异性分别为86.5%和45.4%,荧光膀胱镜检查的敏感性和特异性分别为96.7%和26.6%。没有观察到5 ALA溶液的脑内滴注的局部或全身副作用。总之,ALA诱导的荧光内窥镜检查证明是增加肿瘤检测率的安全方法,尤其是原位和高度恶性PT1G3肿瘤的癌的检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号